Ганодерма луцидум – новые возможности лечения различных патологий в медицине

  • № 3(68) 2017

Страницы: 

14

 – 

21

Язык: русский

Открыть файл статьи
Открыть страницу статьи в Интернет

Аннотация

In this article, new opportunities for treating diseases of the gastrointestinal tract, cardiovascular system, oncology based on biological active supplement based on Ganoderma Lutsidum are disclosed. Mushroom ganoderma Lucidum or Reishi, or Lingzhi, or Trutovik shining grows only in Malaysia, because that’s where the optimum temperature and humid climate. Even before our era. was known mushroom Ganoderma Lucidum. And it was the Chinese doctors who attributed this fungus to the higher fungi, which is several degrees higher than Ginseng. This mushroom was available at that time only to the emperors, since it rarely grows in the wild, and the man who found this mushroom was rewarded generously. Since that time, Chinese doctors have learned to produce ganoderma lucidum on plantations. But artificially grown Ganoderma, when properly executed plantation technique, does not differ from the natural one. Ganoderma Lucidum contains triterpenoids, unsaturated fatty acids, the whole complex of essential amino acids, vitamins (group B, vitamin C), organic germanium, iron, molybdenum, zinc, β-polyglucans (polysaccharides).

Список использованных источников

  1. Бондарцева М.А. Определитель грибов России. Пор. Афиллофоровые. вып. 2. Санкт-Петербург: Наука, 1998. - 390 с.
  2. Бухало А.С. Высшие съедобные базидиомицеты в чистой культуре. Киев: Наукова думка, 1988.- 176 с.
  3. Денисова Н.П. Лечебные свойства грибов. Этномикологический очерк. Санкт-Петербург: СПГМУ, 1998. - 60 с.
  4. Дудка И.А., Бисько Н.А., Бухало А.С., Вассер С.П., Кулиш М.Д., Соломко Э.Ф., Шевченко С.В. Высшие съедобные базидиомицеты в поверхностной и глубинной культуре. Киев: Наукова думка, 1983. - 311 с.
  5. Захаров И.А., Касперавичюс М.М. Грибы в мифах и обрядах. Краткий очерк этномикологии // Микологии и фитопатология. 1981. - Т. 15, № 1. - С. 66-72.
  6. Захарова И.Я., Косенко JI.B. Методы изучения микробных полисахаридов. — Киев: Наукова думка, 1982.-192 с.
  7. Максимов В.Н. Многофакторный эксперимент в биологии.-М.:Из-во МГУ, 1980. 280с.
  8. Максимов В.Н., Федоров В.Д. Применение методов математического планирования эксперимента. М.: МГУ, 1969. - 128 с.
  9. Методы экспериментальной микологии: Справочник / Под ред. В.И. Билай. Киев: Наукова думка, 1982. - 550 с.
  10. Решетников С.В. Эволюция бесполого размножения высших базидиомицетов. Киев: Наукова думка, 1991. - 187 с.
  11. Тадаши Г., Мелик-Оганджанян Р.Г., Мнацаканян В.А. Изучение и использование свойств гриба Ganoderma lucidum (Fr.) Karst. в современной медицинской практике. //  Альтернативная медицина. 1998, январь-март. - С.29-36.
  12. Шиврина А.Н. Биологически активные вещества высших грибов.-Л.:Наука, 1965.-199 с.
  13. Шиврина А.Н., Низковская О.П., Фалина Н.Н., Маттисон Н.Л., Ефименко О.М. Биосинтетическая деятельность высших грибов. Л.: Наука, 1969. - 243 с.
  14. Adaskaveg J.E., Gilbertson R.L. Cultural studies and genetics of sexuality of Ganoderma lucidum and G. tsugae in relation to the taxonomy of the G. lucidum complex //Mycologia. -1986. Vol. 78, № 5. - P.694-705.
  15. Adaskaveg J. E., Gilbertson R. L. Basidiospores, pilocystidia, and other basidiocarp characters in several species of the Ganoderma lucidum complex // Mycologia. 1998. V. 80 (4), p. 493-507
  16. Adaskaveg J.E., Gilbertson R.L. Vegetative incompatibility between intraspecific dikaryoticparings of Ganoderma lucidum and G. tsugae. // Mycologia. 1987. - Vol. 79, № 4. - P.603-613.
  17. Bao X.F., Fang J.N., Li X.Y. Structural characterization and immunomodulating activity of a complex glucan from spores of Ganoderma lucidum // Bioscience Biotechnology and Biochemistry. 2001. v. 65. p. 2384-2391
  18. Bao X.F., Zhen Y., Ruan L., Fang J.N. Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum // Chemical and  Pharmaceutical Bulletin. 2002. - Vol. 50, № 5. - P.623-629.
  19. Bao X.F., Wang X.S., Dong Q., Fang J.N., Li X.Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum// Phytochemistry. 2002. - Vol 59. - P. 175-181.
  20. Berovic M., Habijanic J., Zore I., Wraber В., Hodzar D., Boh B. Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides // Journal of  Biotechnology. 2003. - Vol. 103. - P. 77-86.
  21. Cao L.Z., Lin Z. Regulation on maturation and function of dendric cells Ganoderma lucidum polysaccharides // Immunology Letters. 2002. - Vol. 83, № 3. - P. 163-169.
  22. Cao L.Z. Lin Z.B. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro // Acta Pharmacological Sinica. 2003. - Vol. 24,№4.-P. 312-326.
  23. Cao Q.Z., Lin Z.B. Antitumor and antiangiogenic activity of Ganoderma lucidum polysaccharides peptide // Acta Pharmacological Sinica. 2004. - Vol. 25, № 6. - P.833-838.
  24. Chang H. M . and But P.P.H. Pharmacology and Applications of Chinese Materia Medica. Vol. 1. Singapore: World Scientific Inc., 1986. - 521 p.
  25. Chang Y.W., Lu T.J. Molecular characterization of polysaccharides in hotwater extracts ofGanoderma lucidum fruiting bodies // Journal of Food and Drug Analysis. 2004. - Vol. 12, № 1. - P. 59-67.
  26. Chen Alice W. Ganoderma lucidum (Reishi): cultivation in North America // Science and cultivation of mushrooms. Nanjing, China, 1998. - p. 175-197.
  27. Chen A.W. Cultivation of medicinal mushroom Ganoderma lucidum (Curt.: Fr.) P.Karst ^ (reishi)// International Journal of Medicinal Mushrooms. 1999. - Vol. 1. - P.263-282.
  28. D’Souza T.M., Merrit C.S., Reddy C.A. Lignin-modifying enzymes of the white rot basidiomycete Ganoderma lucidum // Applied and Environmental Microbiology. 1999. V. 65. p. 5307-5313
  29. Eo S.K., Kim Y.S., Lee C.K., Han S.S. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum // Journal of Ethnopharmacology. 1999. V. 68. p. 139-136
  30. Gao J.J., Min B.S., Ahn E.M., Nakamura N, Lee H.K., Hattori M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells // Chemical & Pharmaceutical Bulletin. 2002. V. 50. p. 837-840.
  31. Habijanic J., Berovic M., Paber B., Hodzar D., Boh B. Immunostimulatory effects of fungal polysaccharides from Ganoderma lucidum submerged biomass cultivation//Food Technology and Biotechnology. 2001. V. 39. p. 327-331
  32. El-Mekkawy S., Meselhy M.r., Nakamura H., Tezuka Y., Hattori M., Kakiuchi N., Shomotonho K., Kawahata Т., Otake T. Anti-HIV and anti-HIV-l-protease substances from Ganoderma lucidumll Phytochemistry. 1998. - Vol. 49, № 6. - P. 1651-1657.
  33. Eo S.K., Kim Y.S., Lee C.K., Han S.S. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses // Journal of Ethnopharmacology. 2000. - Vol.72, № 3. - P.475-481.
  34. Fang Q.H and, Zhong J.J Two-Stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidumll Biotechnology Progress. -2002a. Vol. 18, № 1. - P. 51 -54.
  35. Fang Q.-H. and Zhong J.-J. Effect of initial pH on production of ganoderic acid andpolysaccharide by submerged fermentation of Ganoderma lucidum II Process Biochemistry. -2002b. Vol. 37, № 7. - P. 769-774
  36. Fang Q.-H. and Zhong J.-J. Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites—ganoderic acid and polysaccharide // Biochemical Engineering Journal. 2002c. -Vol. 10, № 1. - P.61-65.
  37. Fang Q.-H., Tang Y.-J. and Zhong J.-J. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum II Process Biochemistry. 2002. - Vol. 37, № 12. - P. 1375-1379.
  38. Furusawa E., Chou S.C. Furusawa S., Hirazum A., Dang Y. Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergeneic mice // Phytotherapy Research. 1992. - Vol.6. - P. 300-304.
  39. Gao Y., Zhou S., Huang Min and Xu Anlong. Antibacterial and antiviral value of the genus Ganoderma P.Karst. species (Aphyllophormycetideae): a review // International Journal of Medicinal Mushrooms. 2003. - Vol. 5, № 3. - P.235-246.
  40. Habijanic J., Berovic M., Wraber В., Hodzar D. and Boh B. Immunostimulatory Effects of Fungal Polysaccharides from Ganoderma lucidum Submerged Biomass Cultivation // Food Technology and Biotechnology. 2001. - Vol.39, № 4. - P. 327-331.
  41. Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis.// J Altern Complement Med. 2007 Nov;13(9):985-987.
  42. Hikino H. and Mizuno T. Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies// Planta Medica. 1989. - Vol. 55. - P.385.
  43. Hikino H., Konno C., Mirin Y., Hayashi T. Oriental medicines. Part 91.Antidiabetes drugs. Isolation and hypoglycemic activity of ganoderans A and B: glycan of Ganoderma lucidum fruit bodies // Planta Medica. 1985. - Vol.51. - P.339-340.
  44. Hikino H., Ishiyama M., Suizuki Y., Konno C. Mechanisms of hypoglycemic activity of ganoderan B: glycan of Ganoderma lucidum fruit bodies // Planta Medica. -1989. Vol.55. -P. 423-428.
  45. Hirotani M., Furuya Т., Shiro M. A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum// Phytochemistry. 1985. - Vol. 24, № 9. - P. 2055-2061.
  46. Hirotani M., Ino C., Furuya Т., Shiro M. Ganoderic T, S and R, new triterpenoids from the cultured mycelium of Ganoderma lucidum // Chemical and Pharmaceutical Bulletin. 1986. -Vol.34. -P.2282-2285.
  47. Hobbs C. Medicinal Mushrooms: an Exploration of Tradition, Healing and Cultures. -Interweave Press, 1995. 251 p.
  48. Hsu M.J., Lee S.S., Lin W.W. Signaling mechanism of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum II British Journal of Pharmacology. 2003. - Vol. 139. - P. 289-298.
  49. Hu Y.H., Lin Z.B. Effects of polysaccharides isolated from mycelia of Ganoderma lucidumon HL-60 cell apoptosis // Acta Pharmacologica Sinica. 1999. - Vol. 34. - P. 268-271.
  50. Ito H., Naruse S., Shimura K. Studies on antitumor activity of basidiomycete polysaccharides: VII. Antitumor effect of the polysaccharide preparation from Ganoderma lucidum on mouse Sarcoma 180 // Mie Medical Journal. 1977. - Vol. 26. - P.147-152.
  51. Jong S.C., Birmingham J.M. Medicinal Benefits of the Mushrooms Ganoderma II Advances in Applied Microbiology.-1992. -Vol. 37.-P.101-134.
  52. Kavagishi H., Mitsunaga S., Yamawaki M., Ido M., Shimada A., Kinoshita Т., Murata Т., Usui Т., Kimura A., Chiba S. A lectin from mycelia of the fungus Ganoderma lucidum // Phytochemistry. 1997. - Vol. 44. - P.7-10.
  53. Kim S.W., Hwang H.J., Park J.P., Cho Y.J., Song C.H., Yun J.W. Mycelial growth and exo-biopolymer production by submerged culture of various edible mushrooms under different media // Letters in applied microbiology. -2002. Vol.34, № 1. - P.56-61.
  54. Kim H.W. and Kim B.K. Biomedicinal triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst (Aphyllophoromycetidae) // International Journal of Medicinal Mushrooms. 1999. -Vol. l.-P. 121-138.
  55. Kim B.K., Kim R.S., and Kim H.W. Effects of Ganoderma lucidum on human leukocytes// Proceedings of the 1st International Symposium on Ganoderma lucidum in Japan. — Tokyo, 1997.-P. 87-89.
  56. Kim D.H., Shim S.B., Kim N.J., Jang I.S. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum // Biological and Pharmaceutical bulletin. — 1999. Vol.22,№2.-P. 162-164.
  57. Kimura Y., Okuda H., Arichi S. Effect of the extracts of Ganoderma lucidum on bloodglucose level in rats// Planta Medica. -1988. Vol. 54. - P.290-294.
  58. Hu H., Aim N.S., Yang X., Lee Y.S., Kang K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell // Intern. J. Cancer. 2002. V. 102. P. 250-253
  59. Jiang, J. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling / J. Jiang, V. Slivova, D. Sliva // Int J Oncol. 2006. - Vol. 29, N 3. - P. 695-703.
  60. Kimura Y., Taniguchi M., Baba K. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance // Anticancer Res. 2002. V. 22. P. 3309-3318.
  61. Sliva D. Ganoderma lucidum (reishi) in cancer treatment // Integr. Cancer Ther. 2003. V. 2. P. 358-364.
  62. Sliva D., Labarrere C, Slivova V., Sedlak M., Lloyd F.P. Jr., Ho N.W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells // Biochem. and Biophys. Res. Commun. 2002. V. 298. P. 603-612.
  63. Lin Z. В., Zhang H. N. Anti-tumor and immunoregulatory activites of Ganoderma lucidum and its possible mechanism.// Acta. Pharmacol. Sin. 2004. - 25(11). -P. 1387-1395.
  64. Qi G(1), Hua H, Gao Y, Lin Q, Yu GY. Effects of Ganoderma lucidum spores on sialoadenitis of nonobese diabetic mice.// Chin Med J (Engl). 2009 Mar 5;122(5):556-560.

Список всех публикаций, цитирующих данную статью